These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 30739810)

  • 1. Reply - Letter to the Editor - Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
    Kaido T; Kamo N; Uemoto S
    Clin Nutr; 2019 Apr; 38(2):967. PubMed ID: 30739810
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of sarcopenic obesity on outcomes in patients undergoing living donor liver transplantation.
    Isıklar A; Safer U; Binay Safer V; Yiyit N
    Clin Nutr; 2019 Apr; 38(2):964-965. PubMed ID: 30739808
    [No Abstract]   [Full Text] [Related]  

  • 3. Sarcopenic obesity with metabolic syndrome: a newly recognized entity following living donor liver transplantation.
    Choudhary NS; Saigal S; Saraf N; Mohanka R; Rastogi A; Goja S; Menon PB; Mishra S; Mittal A; Soin AS
    Clin Transplant; 2015 Mar; 29(3):211-5. PubMed ID: 25594826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Sarcopenic Obesity on Outcomes of Living-Donor Liver Transplantation for Hepatocellular Carcinoma.
    Itoh S; Yoshizumi T; Kimura K; Okabe H; Harimoto N; Ikegami T; Uchiyama H; Shirabe K; Nishie A; Maehara Y
    Anticancer Res; 2016 Jun; 36(6):3029-34. PubMed ID: 27272822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of pretransplant sarcopenia and sequential changes in sarcopenic parameters after living donor liver transplantation.
    Kaido T; Tamai Y; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Yagi S; Kamo N; Hammad A; Inagaki N; Uemoto S
    Nutrition; 2017 Jan; 33():195-198. PubMed ID: 27649861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reply to the letter to the editor How is sarcopenic obesity positioned in the "obesity paradox"?
    Sabatino A; Avesani C
    Clin Nutr; 2023 Nov; 42(11):2287-2288. PubMed ID: 37775416
    [No Abstract]   [Full Text] [Related]  

  • 9. Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?
    Rosenthal BE; Bittermann T
    Liver Transpl; 2024 Apr; 30(4):345-346. PubMed ID: 37773049
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative low muscle mass has a strong negative effect on pulmonary function in patients undergoing living donor liver transplantation.
    Shirai H; Kaido T; Hamaguchi Y; Yao S; Kobayashi A; Okumura S; Kamo N; Yagi S; Okajima H; Uemoto S
    Nutrition; 2018 Jan; 45():1-10. PubMed ID: 29129228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?
    Kocher NJ; Jafri S; Balabhadra S; Lehman E; Gardner J; Vijay K; Sarwani N; Raman JD
    Urol Oncol; 2018 Apr; 36(4):156.e17-156.e22. PubMed ID: 29276063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comment on "Impact of sarcopenia on survival in patients undergoing living donor liver transplantation".
    Safer U; Tasci I; Binay Safer V; Doruk H
    Am J Transplant; 2013 Sep; 13(9):2505. PubMed ID: 23915024
    [No Abstract]   [Full Text] [Related]  

  • 13. Sarcopenia is a prognostic factor in living donor liver transplantation.
    Masuda T; Shirabe K; Ikegami T; Harimoto N; Yoshizumi T; Soejima Y; Uchiyama H; Ikeda T; Baba H; Maehara Y
    Liver Transpl; 2014 Apr; 20(4):401-7. PubMed ID: 24357065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait Speed.
    Harimoto N; Yoshizumi T; Izumi T; Motomura T; Harada N; Itoh S; Ikegami T; Uchiyama H; Soejima Y; Nishie A; Kamishima T; Kusaba R; Shirabe K; Maehara Y
    Transplant Proc; 2017 Nov; 49(9):2144-2152. PubMed ID: 29149975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria.
    Kim YR; Park S; Han S; Ahn JH; Kim S; Sinn DH; Jeong WK; Ko JS; Gwak MS; Kim GS
    Sci Rep; 2018 May; 8(1):7157. PubMed ID: 29740069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia, obesity and sarcopenic obesity: effects on liver function and volume in patients scheduled for major liver resection.
    Lodewick TM; Roeth AA; Olde Damink SW; Alizai PH; van Dam RM; Gassler N; Schneider M; Dello SA; Schmeding M; Dejong CH; Neumann UP
    J Cachexia Sarcopenia Muscle; 2015 Jun; 6(2):155-63. PubMed ID: 26136191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-glutamyl transferase is associated with sarcopenia and sarcopenic obesity in community-dwelling older adults: results from the Fifth Korea National Health and Nutrition Examination Survey, 2010-2011.
    Hong N; Lee EY; Kim CO
    Endocr J; 2015; 62(7):585-92. PubMed ID: 25913781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to the letter "Waist circumference or sarcopenic obesity; which is more predictive?".
    Liao Q; Xiu S; Chan P
    Aging Clin Exp Res; 2019 Oct; 31(10):1539-1540. PubMed ID: 31368090
    [No Abstract]   [Full Text] [Related]  

  • 19. Sarcopenia and sarcopenic obesity among men aged 80 years and older in Beijing: prevalence and its association with functional performance.
    Meng P; Hu YX; Fan L; Zhang Y; Zhang MX; Sun J; Liu Y; Li M; Yang Y; Wang LH; Zhang Y; Gao W; Han XQ; Chen LK
    Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():29-35. PubMed ID: 24450558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenic obesity: A probable risk factor for dose limiting toxicity during neo-adjuvant chemotherapy in oesophageal cancer patients.
    Anandavadivelan P; Brismar TB; Nilsson M; Johar AM; Martin L
    Clin Nutr; 2016 Jun; 35(3):724-30. PubMed ID: 26065721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.